Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles

被引:44
作者
Bravo-Osuna, I. [1 ]
Vauthier, C. [1 ]
Chacun, H. [1 ]
Ponchel, G. [1 ]
机构
[1] Univ Paris Sud, Fac Pharm, Lab Physicochim Pharmacotech & Biopharm, CNRS,UMR 8612, F-92296 Chatenay Malabry, France
关键词
chitosan; thiolated chitosan; poly(isobutylcyanoacrylate); core-shell/core-corona nanoparticles; permeation enhancement; TEER; ussing-type chambers;
D O I
10.1016/j.ejpb.2007.12.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work is focused on the evaluation of the in vitro permeation modulation of chitosan and thiolated chitosan (chitosan-TBA) coated poly(isobutylcyanoacrylate) (PIBCA) nanoparticles as drug carriers for mucosal administration. Core-corona nanoparticles were obtained by radical emulsion polymerisation of isobutylcyanoacrylate (IBCA) with chitosan of different molecular weights and different proportions of chitosan/chitosan-TBA. In this work, the effect of these nanoparticles on the paracellular permeability of intestinal epithelium was investigated using the Ussing chamber technique, by adding nanoparticle suspensions in the mucosal side of rat intestinal mucosa. Results showed that permeation of the tracer [C-14]mannitol and the reduction of transepithelial electrical resistance (TEER) in presence of nanoparticles were more pronounced in those formulations prepared with intermediate amounts of thiolated polymer. This effect was explained thanks to the high diffusion capacity of those nanoparticles through the mucus layer that allowed them to reach the tight junctions in higher extent. It was concluded that, although a first contact between nanoparticles and mucus was a mandatory condition for the development of a permeation enhancement effect, the optimal effect depended on the chitosan/chitosan-TBA balance and the conformational structure of the particles shell. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:436 / 444
页数:9
相关论文
共 44 条
[21]   Luminal adenosine stimulates chloride secretion through A1 receptor in mouse jejunum [J].
Ghanem, E ;
Lövdahl, C ;
Daré, E ;
Ledent, C ;
Fredholm, BB ;
Boeynaems, JM ;
Van Driessche, W ;
Beauwens, R .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (05) :G972-G977
[22]   IN-VITRO SYSTEMS FOR STUDYING INTESTINAL DRUG ABSORPTION [J].
HILLGREN, KM ;
KATO, A ;
BORCHARDT, RT .
MEDICINAL RESEARCH REVIEWS, 1995, 15 (02) :83-109
[23]   Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation [J].
Huang, M ;
Khor, E ;
Lim, LY .
PHARMACEUTICAL RESEARCH, 2004, 21 (02) :344-353
[24]   Chitosan as a novel nasal delivery system for vaccines [J].
Illum, L ;
Jabbal-Gill, I ;
Hinchcliffe, M ;
Fisher, AN ;
Davis, SS .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :81-96
[25]   Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? [J].
Jung, T ;
Kamm, W ;
Breitenbach, A ;
Kaiserling, E ;
Xiao, JX ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :147-160
[26]  
Khan TA, 2000, J PHARM PHARM SCI, V3, P303
[27]   Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2) [J].
Kotze, AF ;
Luessen, HL ;
de Leeuw, BJ ;
de Boer, BG ;
Verhoef, JC ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (01) :35-46
[28]  
Kumar M.N. V Ravi., 2000, REACT FUNCT POLYM, V46, P1, DOI [DOI 10.1016/S1381-5148(00)00038-9, 10.1016/S1381-5148(00)00038-9]
[29]   The depolymerization of chitosan: effects on physicochemical and biological properties [J].
Mao, SR ;
Shuai, XT ;
Unger, F ;
Simon, M ;
Bi, DZ ;
Kissel, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 281 (1-2) :45-54
[30]   Permeability of human jejunal segments to gonyautoxins measured by the Ussing chamber technique [J].
Mardones, P ;
Andrinolo, D ;
Csendes, A ;
Lagos, N .
TOXICON, 2004, 44 (05) :521-528